MONONGAHELA VALLEY HOSPITAL INC.
1. Target Overview & Investment Thesis
MONONGAHELA VALLEY HOSPITAL INC. is a 184-bed community hospital in WASHINGTON, PA with $113.8M in net patient revenue and a -13.4% operating margin. The hospital serves a payer mix of 0.0% Medicare, 0.7% Medicaid, and 99.3% commercial.
Thesis: Undervalued. Our ML models identify $8.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.4% to -6.0% (+736bps).
| Net Revenue HCRIS | $113.8M |
| Current EBITDA COMPUTED | $-15.2M |
| Operating Margin COMPUTED | -13.4% |
| Occupancy HCRIS | 29.9% |
| Revenue / Bed COMPUTED | $619K |
| Net-to-Gross HCRIS | 28.0% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -13.4% places it below the state median. Among 100 size-comparable peers (92-368 beds), the median margin is -7.5%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (92-368), prioritizing same-state peers. 100 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MONONGAHELA VALLEY HOSPITAL IN (Target) | PA | 184 | $113.8M | -13.4% |
| PRESBYTERIAN MEDICAL CENTER | PA | 328 | $988.5M | -18.9% |
| UPMC MAGEE-WOMENS HOSPITAL | PA | 347 | $910.8M | -23.9% |
| UPMC CHILDRENS HOSPITAL OF PGH | PA | 317 | $816.7M | -2.5% |
| GEISINGER WYOMING VALLEY MED C | PA | 309 | $782.7M | 5.9% |
| WESTERN PENNSYLVANIA HOSPITAL | PA | 255 | $776.4M | 11.1% |
| UPMC ALTOONA | PA | 337 | $526.8M | -4.8% |
| COMMUNITY MEDICAL CENTER | PA | 266 | $474.1M | 3.1% |
| THE CHESTER COUNTY HOSPITAL | PA | 299 | $473.6M | -8.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $73K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-15.2M |
| + RCM Uplift | +$8.4M |
| Pro Forma EBITDA | $-6.8M |
| Current Margin | -13.4% |
| Pro Forma Margin | -6.0% |
| WC Released (1x) | $4.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-23.4M | $-16.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-23.4M | $-25.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-21.0M | $-5.7M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-21.0M | $-12.4M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-25.7M | $-50.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-25.7M | $-64.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 29.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 100 hospitals with 92-368 beds
- Same-state prioritization (n=101)
- Comp margins: P25=-18.7% / P50=-7.5% / P75=2.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.